CHARLES GARDNER: Open Payments
NPI 1881763670 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 20 payments from 10 companies in 2025. Trend: 2023 $483 · 2024 $846 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $143 |
| Amgen Inc. | 3 | $67 |
| ABBVIE INC. | 3 | $66 |
| Lilly USA, LLC | 2 | $40 |
| Exact Sciences Corporation | 1 | $27 |
| Becton, Dickinson and Company | 1 | $24 |
| PFIZER INC. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Ozempic, Wegovy, UBRELVY, MOUNJARO, EVENITY, KRYSTEXXA, The Cologuard Plus Collection Kit, BD MAX System, BD MAX Instrument.
Industry payments across VA — which companies pay providers there.
